USX:APNHY - Aspen Pharmacare Holdings Limited Aspen Pharmacare Holdings Limi
Sector: Unknown, Industry: Unknown
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 11.77    +0.260 (+2.26%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

16 Jul 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Stephen Bradley Saad

Headquarters: US

Employees: 9,069

Homepage

Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.